Exact Mass: 370.3083

Exact Mass Matches: 370.3083

Found 287 metabolites which its exact mass value is equals to given mass value 370.3083, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Docosanedioic acid

1,20-Eicosanedicarboxylic acid

C22H42O4 (370.3083)


Phellogenic acid, also known as 1,20-eicosanedicarboxylic acid or 1,22-docosanedioate, is a member of the class of compounds known as very long-chain fatty acids. Very long-chain fatty acids are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, phellogenic acid is considered to be a fatty acid lipid molecule. Phellogenic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Phellogenic acid can be found in potato, which makes phellogenic acid a potential biomarker for the consumption of this food product. Docosanedioic acid is an alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids. It has a role as a metabolite. It is an alpha,omega-dicarboxylic acid and a dicarboxylic fatty acid. It is a conjugate acid of a docosanedioate(2-). It derives from a hydride of a docosane. Docosanedioic acid is a natural product found in Pinus radiata with data available.

   

Diethylhexyl adipate

Hexanedioic acid, 1,6-bis(2-ethylhexyl) ester

C22H42O4 (370.3083)


Diethylhexyl adipate (DEHA) is an indirect food additive arising from contact with polymers and adhesives. DEHA is a plasticizer. DEHA is an ester of 2-ethylhexanol and adipic acid. Its chemical formula is C22H42O4. Indirect food additive arising from contact with polymers and adhesives

   

Naspm

1-Naphthylacetylspermine

C22H34N4O (370.2732)


Naspm (1-Naphthyl acetyl spermine), a synthetic analogue of Joro spider toxin, is a calcium permeable AMPA (CP-AMPA) receptors antagonist.

   

B-Norcholest-4-en-3-one

B-Norcholest-4-en-3-one

C26H42O (370.3235)


   

Stellatic acid

Stellatate; Stellatic acid

C25H38O2 (370.2872)


A sesterterpenoid with formula C25H38O2 which is isolated from the fungus Emericella variecolor.

   

(3beta,22E)-26,27-Dinorergosta-5,22-dien-3-ol

2,15-dimethyl-14-[(3Z)-5-methylhex-3-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-ol

C26H42O (370.3235)


(3beta,22E)-26,27-Dinorergosta-5,22-dien-3-ol is found in crustaceans. (3beta,22E)-26,27-Dinorergosta-5,22-dien-3-ol is a constituent of Mytilus edulis (blue mussel) and other crustaceans, molluscs and sponges Constituent of Mytilus edulis (blue mussel) and other crustaceans, molluscs and sponges. (3beta,22E)-26,27-Dinorergosta-5,22-dien-3-ol is found in crustaceans.

   

Asterosterol

2,15-dimethyl-14-[(3Z)-5-methylhex-3-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-ol

C26H42O (370.3235)


Asterosterol is found in mollusks. Asterosterol is found in clams and oyster Found in clams and oysters

   

trans-2-Tetradecenoylcarnitine

(3R)-3-[(2E)-Tetradec-2-enoyloxy]-4-(trimethylazaniumyl)butanoic acid

C21H40NO4 (370.2957)


trans-2-Tetradecenoylcarnitine is an acylcarnitine. More specifically, it is an trans-2-tetradecenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. trans-2-Tetradecenoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine trans-2-tetradecenoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular trans-2-tetradecenoylcarnitine is elevated in the blood or plasma of individuals with very long-chain acyl-CoA dehydrogenase (VLACD) deficiency (PMID: 25843429, PMID: 19327992, PMID: 11433098, PMID: 18670371, PMID: 12828998), trifunctional protein (mitochondrial long-chain ketoacyl-coa thiolase) deficiency (PMID: 16423905), mitochondrial dysfunction in diabetes patients (PMID: 28726959), acadvl acyl-coa dehydrogenase very long chain deficiency (PMID: 29491033), nonalcoholic fatty liver disease (NAFLD) (PMID: 27211699), and insulin resistance type 2 diabetes (PMID: 24358186). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane.  Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Dioctyl hexanedioate

1,6-dioctyl hexanedioate

C22H42O4 (370.3083)


Dioctyl hexanedioate is a food additive [Goodscents]. Food additive [Goodscents]

   

Myristoleoylcarnitine

(3R)-3-[(9Z)-tetradec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate

C21H40NO4 (370.2957)


Myristoleoylcarnitine is an acylcarnitine. More specifically, it is an myristoleoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Myristoleoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine myristoleoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular myristoleoylcarnitine is elevated in the blood or plasma of individuals with very long-chain acyl-CoA dehydrogenase (VLACD) deficiency (PMID: 25843429, PMID: 19327992, PMID: 11433098, PMID: 18670371, PMID: 12828998), trifunctional protein (mitochondrial long-chain ketoacyl-coa thiolase) deficiency (PMID: 16423905), mitochondrial dysfunction in diabetes patients (PMID: 28726959), acadvl acyl-coa dehydrogenase very long chain deficiency (PMID: 29491033), nonalcoholic fatty liver disease (NAFLD) (PMID: 27211699), and insulin resistance type 2 diabetes (PMID: 24358186).Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane.  Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). Myristoleoylcarnitine has also been identified in the human placenta (PMID: 32033212 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Palmitoyl Asparagine

[4-(propoxycarbonyl)phenyl]oxidanesulfonic acid

C20H38N2O4 (370.2831)


N-palmitoyl asparagine, also known as propyl paraben sulfate or propyl 4-sulfooxybenzoate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Asparagine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Glycerylmonooleate

2,3-dihydroxypropanoyl octadec-9-enoate

C21H38O5 (370.2719)


   

MG(18:1(12Z)-O(9S,10R)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid

C21H38O5 (370.2719)


MG(18:1(12Z)-O(9S,10R)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(18:1(9Z)-O(12,13)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid

C21H38O5 (370.2719)


MG(18:1(9Z)-O(12,13)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:1(12Z)-O(9S,10R)/0:0)

1,3-Dihydroxypropan-2-yl 8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid

C21H38O5 (370.2719)


MG(0:0/18:1(12Z)-O(9S,10R)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:1(9Z)-O(12,13)/0:0)

1,3-dihydroxypropan-2-yl (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C21H38O5 (370.2719)


MG(0:0/18:1(9Z)-O(12,13)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Erythrophloin B

Erythrophloin B

C25H38O2 (370.2872)


   

23-hydroxytricosanoic Acid

23-hydroxytricosanoic Acid

C23H46O3 (370.3447)


   

Myristamidopropyl betaine

Myristamidopropyl betaine

C21H42N2O3 (370.3195)


   

nonadecatrienylresorcinol

nonadecatrienylresorcinol

C25H38O2 (370.2872)


   

(3beta,22Z)-26,27-Dinorergosta-5,22-dien-3-ol

(3beta,22Z)-26,27-Dinorergosta-5,22-dien-3-ol

C26H42O (370.3235)


   

Luffarin Q|luffarin-Q

Luffarin Q|luffarin-Q

C25H38O2 (370.2872)


   

Acetylconanin|N-Acetyl-conimin

Acetylconanin|N-Acetyl-conimin

C24H38N2O (370.2984)


   

Cericeroic acid

Cericeroic acid

C25H38O2 (370.2872)


   

Gascardsaeure|Gascardsaeure, acide gascardique

Gascardsaeure|Gascardsaeure, acide gascardique

C25H38O2 (370.2872)


   

Me ester-(ent-2beta,3alpha,4alpha,13S)-2,3,4-Trihydroxy-15-clerodanoic acid|methyl 2alpha,3beta,4beta-trihydroxy-neo-clerodan-15-oate

Me ester-(ent-2beta,3alpha,4alpha,13S)-2,3,4-Trihydroxy-15-clerodanoic acid|methyl 2alpha,3beta,4beta-trihydroxy-neo-clerodan-15-oate

C21H38O5 (370.2719)


   

Albolsaeure

Albolsaeure

C25H38O2 (370.2872)


   

Ceroplasterinsaeure; 6alpha.10beta.11alpha-Delta3(20).7.18-Ophiobolatrien-25-saeure|Ophiobolic acid

Ceroplasterinsaeure; 6alpha.10beta.11alpha-Delta3(20).7.18-Ophiobolatrien-25-saeure|Ophiobolic acid

C25H38O2 (370.2872)


   

19-Nor-cholest-4-en-3-on|19-nor-cholest-4-en-3-one|19-norcholest-4-en-3-one

19-Nor-cholest-4-en-3-on|19-nor-cholest-4-en-3-one|19-norcholest-4-en-3-one

C26H42O (370.3235)


   

2-Hydroxytricosanoic acid

2-hydroxy Tricosanoic Acid

C23H46O3 (370.3447)


A 2-hydroxy fatty acid that is tricosanoic acid substituted by a hydroxy group at position 2.

   

2,3-dihydroxypropyl (9Z,12Z)-11-hydroxyoctadeca-9,12-dienoate

2,3-dihydroxypropyl (9Z,12Z)-11-hydroxyoctadeca-9,12-dienoate

C21H38O5 (370.2719)


   

Asterosterol

2,15-dimethyl-14-[(3Z)-5-methylhex-3-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-ol

C26H42O (370.3235)


   

Gascardic acid

Gascardic acid

C25H38O2 (370.2872)


   

SCHEMBL11822487

SCHEMBL11822487

C21H38O5 (370.2719)


   

18R-hydroxydihydroalloprotolichesterinic acid

18R-hydroxydihydroalloprotolichesterinic acid

C21H38O5 (370.2719)


   

2-O-(9-oxooctadec-cis-12-enoyl)glycerol

2-O-(9-oxooctadec-cis-12-enoyl)glycerol

C21H38O5 (370.2719)


   

floceric acid

floceric acid

C25H38O2 (370.2872)


   

12-deacetoxyscalaradial|desacetoxyscalaradial

12-deacetoxyscalaradial|desacetoxyscalaradial

C25H38O2 (370.2872)


   

Dimethyl icosanedioate

Dimethyl icosanedioate

C22H42O4 (370.3083)


   

2-hydroxyoctadec-1-yl pentanoate

2-hydroxyoctadec-1-yl pentanoate

C23H46O3 (370.3447)


   

13-Hydroxydocosanoic acid methyl ester

13-Hydroxydocosanoic acid methyl ester

C23H46O3 (370.3447)


   

1-O-(2-Hydroxy-4-cis-hexadecenyl)-2,3-isopropylidenglycerol

1-O-(2-Hydroxy-4-cis-hexadecenyl)-2,3-isopropylidenglycerol

C22H42O4 (370.3083)


   
   

(E)-24-nor-cholest-22-en-3-one

(E)-24-nor-cholest-22-en-3-one

C26H42O (370.3235)


   

Raoulic acid

Raoulic acid

C25H38O2 (370.2872)


   

carduusyne A ethyl ester|carduusyne-A ethyl ester

carduusyne A ethyl ester|carduusyne-A ethyl ester

C25H38O2 (370.2872)


   

METHYL 22-HYDROXYDOCOSANOATE

METHYL 22-HYDROXYDOCOSANOATE

C23H46O3 (370.3447)


   

alpha-(15-hydroxyhexadecyl)itaconic acid

alpha-(15-hydroxyhexadecyl)itaconic acid

C21H38O5 (370.2719)


   

3beta-Hydroxy-26,27-bis-nor-22-trans-chloesta-5,22-dien-24-on

3beta-Hydroxy-26,27-bis-nor-22-trans-chloesta-5,22-dien-24-on

C25H38O2 (370.2872)


   

Methyl 2-hydroxydocosanoate

2-hydroxy Docosanoic Acid methyl ester

C23H46O3 (370.3447)


   

(10Z,13Z,16Z)-5-(nonadeca-10,13,16-trienyl)resorcinol

(10Z,13Z,16Z)-5-(nonadeca-10,13,16-trienyl)resorcinol

C25H38O2 (370.2872)


   

carbomethoxyoctadecanol acetate

carbomethoxyoctadecanol acetate

C22H42O4 (370.3083)


   

2R,4R-diacetoxy-1-hydroxy-n-heptadeca-16-ene

2R,4R-diacetoxy-1-hydroxy-n-heptadeca-16-ene

C21H38O5 (370.2719)


   

C(C)(=O)OCC(CC(CCCCCCCCCCCC=C)O)OC(C)=O

C(C)(=O)OCC(CC(CCCCCCCCCCCC=C)O)OC(C)=O

C21H38O5 (370.2719)


   

plakortide U

plakortide U

C22H42O4 (370.3083)


   

(+)-12beta,17-epoxyemericella-3E,7E,22-trien-16-al|emericellene A

(+)-12beta,17-epoxyemericella-3E,7E,22-trien-16-al|emericellene A

C25H38O2 (370.2872)


   

SCHEMBL15944389

SCHEMBL15944389

C21H38O5 (370.2719)


   
   

2-Hydroxy-21-methyldocosanoic acid

2-Hydroxy-21-methyldocosanoic acid

C23H46O3 (370.3447)


   

(22E)-24-nor-5alpha-cholesta-8,22-dien-3beta-ol

(22E)-24-nor-5alpha-cholesta-8,22-dien-3beta-ol

C26H42O (370.3235)


   

23-Carboxylic acid-Ceriferol 1|Cericersaeure

23-Carboxylic acid-Ceriferol 1|Cericersaeure

C25H38O2 (370.2872)


   

3-Acetoxy-icosanoic acid

3-Acetoxy-icosanoic acid

C22H42O4 (370.3083)


   

emericolin A

emericolin A

C25H38O2 (370.2872)


   

ceriferic acid

ceriferic acid

C25H38O2 (370.2872)


   
   

Luffarin P|luffarin-P

Luffarin P|luffarin-P

C25H38O2 (370.2872)


   

13-Methoxycericeren|13-Methoxycericerene

13-Methoxycericeren|13-Methoxycericerene

C26H42O (370.3235)


   

Retigeranic acid

Retigeranic acid

C25H38O2 (370.2872)


   

2-Hydroxy-20-methyl-docosan-1-saeure

2-Hydroxy-20-methyl-docosan-1-saeure

C23H46O3 (370.3447)


   

1-hydroxyoctadec-2-yl pentanoate

1-hydroxyoctadec-2-yl pentanoate

C23H46O3 (370.3447)


   

2-hydroxynonadec-1-yl butanoate

2-hydroxynonadec-1-yl butanoate

C23H46O3 (370.3447)


   

(20S)-20-(N-dimethylamino)-3beta-(N-dimethylamino)-pregn-4,14-diene|hookerianamide K

(20S)-20-(N-dimethylamino)-3beta-(N-dimethylamino)-pregn-4,14-diene|hookerianamide K

C25H42N2 (370.3348)


   

Buxenin G|Nor-buxamin

Buxenin G|Nor-buxamin

C25H42N2 (370.3348)


   

26,27-Bisnorcholest-5-en-23-yn-3beta,7alpha-diol|Gelliusterol A

26,27-Bisnorcholest-5-en-23-yn-3beta,7alpha-diol|Gelliusterol A

C25H38O2 (370.2872)


   

Ac-20-Hydroxyeicosanoic acid

Ac-20-Hydroxyeicosanoic acid

C22H42O4 (370.3083)


   

18-tigloyloxyabieta-7,13(14)-diene

18-tigloyloxyabieta-7,13(14)-diene

C25H38O2 (370.2872)


   

16-deacetoxy-scalarafuran

16-deacetoxy-scalarafuran

C25H38O2 (370.2872)


   

Methyldopexamine

Methyldopexamine

C23H34N2O2 (370.262)


   

2-hydroxy-tricosanoic acid

2-hydroxy-tricosanoic acid

C23H46O3 (370.3447)


   

(3beta,22E)-26,27-Dinorergosta-5,22-dien-3-ol

2,15-dimethyl-14-[(3Z)-5-methylhex-3-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol

C26H42O (370.3235)


   

Dioctyl adipate

1,6-dioctyl hexanedioate

C22H42O4 (370.3083)


   

FA 23:0;O

2-hydroxy-tricosanoic acid

C23H46O3 (370.3447)


   

FA 22:1;O2

3-Acetoxy-eicosanoic acid

C22H42O4 (370.3083)


   

WD 22:1;O2

hexanedioic acid,1,6-bis[(2R)-ethylhexyl] ester

C22H42O4 (370.3083)


   

SFAHFA

2-acetoxy-eicosanoic acid

C22H42O4 (370.3083)


   

FAHFA 22:0;O

3-tetradecanoyloxy-octanoic acid

C22H42O4 (370.3083)


   

ST 26:2;O

24-nor-cholest-5,22E-dien-3beta-ol

C26H42O (370.3235)


   

5-((8Z,11Z,14Z)-nonadeca-8,11,14-trienyl) resorcinol

5-((8Z,11Z,14Z)-nonadeca-8,11,14-trienyl) resorcinol

C25H38O2 (370.2872)


   

Hexanedioic acid, di-C7-9-branched and linear alkyl esters

Hexanedioic acid, di-C7-9-branched and linear alkyl esters

C22H42O4 (370.3083)


   

(carboxymethyl)dimethyl-3-[(1-oxotetradecyl)amino]propylammonium hydroxide

1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxotetradecyl)amino]-, inner salt

C21H42N2O3 (370.3195)


   

N,N-hexane-1,6-diylbis[N-hexylurea]

N,N-hexane-1,6-diylbis[N-hexylurea]

C20H42N4O2 (370.3308)


   

(4-propylphenyl) 4-(4-propylcyclohexyl)cyclohexane-1-carboxylate

(4-propylphenyl) 4-(4-propylcyclohexyl)cyclohexane-1-carboxylate

C25H38O2 (370.2872)


   

Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)-2-methylpropyl]-1-piperazinyl]- (9CI)

Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)-2-methylpropyl]-1-piperazinyl]- (9CI)

C19H30N8 (370.2593)


   

2-octadecylbutanedioic acid

2-octadecylbutanedioic acid

C22H42O4 (370.3083)


   

4,4-(1,11-Undecanediyl)dioxydianiline

4,4-(1,11-Undecanediyl)dioxydianiline

C23H34N2O2 (370.262)


   

3-Hexadecyl-1-methyl-1H-iImidazolium nitrate

3-Hexadecyl-1-methyl-1H-iImidazolium nitrate

C20H40N3O3 (370.307)


   

4-(TRANS-4-PROPYLCYCLOHEXYL)-PHENYL TRANS-4-PROPYLCYCLOHEXANECARBOXYLATE

4-(TRANS-4-PROPYLCYCLOHEXYL)-PHENYL TRANS-4-PROPYLCYCLOHEXANECARBOXYLATE

C25H38O2 (370.2872)


   

Boc-C16-COOH

Boc-C16-COOH

C22H42O4 (370.3083)


   

1,18-bis(Hydrazinocarbonyl)octadecane

1,18-bis(Hydrazinocarbonyl)octadecane

C20H42N4O2 (370.3308)


   

DIISOOCTYL ADIPATE

DIISOOCTYL ADIPATE

C22H42O4 (370.3083)


   

3-METHYL-1-OCTADECYLIMIDAZOLIUM CHLORIDE

3-METHYL-1-OCTADECYLIMIDAZOLIUM CHLORIDE

C22H43ClN2 (370.3115)


   

Penmesterol

methyltestosterone

C25H38O2 (370.2872)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

PB 28 dihydrochloride

1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine

C24H38N2O (370.2984)


   

2-(2-hydroxyethoxy)ethyl monooleate

2-(2-hydroxyethoxy)ethyl monooleate

C22H42O4 (370.3083)


   

1,2-Bis((2S,5S)-2,5-di-i-propylphospholano)ethane

1,2-Bis((2S,5S)-2,5-di-i-propylphospholano)ethane

C22H44P2 (370.2918)


   

N-[2-[(2-hydroxyethyl)amino]ethyl]stearamide

N-[2-[(2-hydroxyethyl)amino]ethyl]stearamide

C22H46N2O2 (370.3559)


   

OCTYLDODECYL LACTATE

OCTYLDODECYL LACTATE

C23H46O3 (370.3447)


   

19-Norcholest-4-en-3-one

19-Norcholest-4-en-3-one

C26H42O (370.3235)


   

Hookerianamide K

Hookerianamide K

C25H42N2 (370.3348)


A steroid alkaloid that is pregn-4,14-diene substituted by N-dimethylamino groups at positions 3 and 20 (the 3beta,20S stereoisomer). Isolated from Sarcococca hookeriana, it exhibits antileishmanial and antibacterial activities.

   

1,3-Dihydroxypropan-2-YL nonadec-9-enoate

1,3-Dihydroxypropan-2-YL nonadec-9-enoate

C22H42O4 (370.3083)


   

Dihexyl sebacate

Dihexyl sebacate

C22H42O4 (370.3083)


   

Trimethylsilyl nonadecanoate

Trimethylsilyl nonadecanoate

C22H46O2Si (370.3267)


   

505-56-6

1,20-Eicosanedicarboxylic acid

C22H42O4 (370.3083)


   

[(2R)-3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

2,3-dihydroxypropanoyl (E)-octadec-9-enoate

2,3-dihydroxypropanoyl (E)-octadec-9-enoate

C21H38O5 (370.2719)


   

[(2R)-3-carboxy-2-[(Z)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(Z)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

MG(18:1(12Z)-O(9S,10R)/0:0/0:0)

MG(18:1(12Z)-O(9S,10R)/0:0/0:0)

C21H38O5 (370.2719)


   

[(2S)-2,3-dihydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2S)-2,3-dihydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C21H38O5 (370.2719)


   

MG(0:0/18:1(12Z)-O(9S,10R)/0:0)

MG(0:0/18:1(12Z)-O(9S,10R)/0:0)

C21H38O5 (370.2719)


   

1,3-dihydroxypropan-2-yl (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

1,3-dihydroxypropan-2-yl (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C21H38O5 (370.2719)


   

[3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-4-enyl]-trimethylazanium

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-4-enyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(4E,6E)-3-hydroxytrideca-4,6-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,6E)-3-hydroxytrideca-4,6-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(6E,9E)-3-hydroxytrideca-6,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,9E)-3-hydroxytrideca-6,9-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(5E,9E)-3-hydroxytrideca-5,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,9E)-3-hydroxytrideca-5,9-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(7E,9E)-5-hydroxytrideca-7,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,9E)-5-hydroxytrideca-7,9-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(8E,11E)-5-hydroxytrideca-8,11-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,11E)-5-hydroxytrideca-8,11-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(6E,8E)-4-hydroxytrideca-6,8-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,8E)-4-hydroxytrideca-6,8-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(5E,8E)-3-hydroxytrideca-5,8-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,8E)-3-hydroxytrideca-5,8-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(5E,7E)-3-hydroxytrideca-5,7-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,7E)-3-hydroxytrideca-5,7-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(8E,10E)-6-hydroxytrideca-8,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,10E)-6-hydroxytrideca-8,10-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(7E,10E)-4-hydroxytrideca-7,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,10E)-4-hydroxytrideca-7,10-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(9E,11E)-7-hydroxytrideca-9,11-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(9E,11E)-7-hydroxytrideca-9,11-dienoyl]oxypropyl]-trimethylazanium

C20H36NO5+ (370.2593)


   

[3-carboxy-2-[(E)-tetradec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-4-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-7-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(3E,5E)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

[(3E,5E)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

Quiannulatic acid

Quiannulatic acid

C25H38O2 (370.2872)


   

[(2R)-3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(2R)-3-carboxy-2-[(E)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(E)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(Z)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-11-enyl]-trimethylazanium

[(Z)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-11-enyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(2S)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

[(2S)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(1S)-3-carboxy-1-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

[(1S)-3-carboxy-1-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

9-Acetyloxyicosanoic acid

9-Acetyloxyicosanoic acid

C22H42O4 (370.3083)


   

9-(Butyryloxy)octadecanoic acid

9-(Butyryloxy)octadecanoic acid

C22H42O4 (370.3083)


   

16-Methyloctadecanoic acid trimethylsilyl ester

16-Methyloctadecanoic acid trimethylsilyl ester

C22H46O2Si (370.3267)


   

Fahfa 18:0/4:0

Fahfa 18:0/4:0

C22H42O4 (370.3083)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentanoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentanoate

C22H42O4 (370.3083)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] butanoate

C22H42O4 (370.3083)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexanoate

C22H42O4 (370.3083)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] propanoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] propanoate

C22H42O4 (370.3083)


   

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] acetate

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] acetate

C22H42O4 (370.3083)


   

2,3-dihydroxypropyl (Z)-nonadec-9-enoate

2,3-dihydroxypropyl (Z)-nonadec-9-enoate

C22H42O4 (370.3083)


   

Fahfa 15:0/7:0

Fahfa 15:0/7:0

C22H42O4 (370.3083)


   

Fahfa 5:0/17:0

Fahfa 5:0/17:0

C22H42O4 (370.3083)


   

Fahfa 19:0/3:0

Fahfa 19:0/3:0

C22H42O4 (370.3083)


   

Fahfa 17:0/5:0

Fahfa 17:0/5:0

C22H42O4 (370.3083)


   

Fahfa 13:0/9:0

Fahfa 13:0/9:0

C22H42O4 (370.3083)


   

Fahfa 3:0/19:0

Fahfa 3:0/19:0

C22H42O4 (370.3083)


   

Fahfa 9:0/13:0

Fahfa 9:0/13:0

C22H42O4 (370.3083)


   

Fahfa 8:0/14:0

Fahfa 8:0/14:0

C22H42O4 (370.3083)


   

Fahfa 7:0/15:0

Fahfa 7:0/15:0

C22H42O4 (370.3083)


   

Fahfa 14:0/8:0

Fahfa 14:0/8:0

C22H42O4 (370.3083)


   

Fahfa 6:0/16:0

Fahfa 6:0/16:0

C22H42O4 (370.3083)


   

Fahfa 16:0/6:0

Fahfa 16:0/6:0

C22H42O4 (370.3083)


   

Fahfa 12:0/10:0

Fahfa 12:0/10:0

C22H42O4 (370.3083)


   

Fahfa 10:0/12:0

Fahfa 10:0/12:0

C22H42O4 (370.3083)


   

Fahfa 11:0/11:0

Fahfa 11:0/11:0

C22H42O4 (370.3083)


   

1-O-(1-Tetradecenyl)-2-O,3-O-diacetylglycerol

1-O-(1-Tetradecenyl)-2-O,3-O-diacetylglycerol

C21H38O5 (370.2719)


   

2-Icosanoyloxyacetic acid

2-Icosanoyloxyacetic acid

C22H42O4 (370.3083)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate

C21H38O5 (370.2719)


   

(1-hydroxy-3-pentanoyloxypropan-2-yl) (Z)-tridec-9-enoate

(1-hydroxy-3-pentanoyloxypropan-2-yl) (Z)-tridec-9-enoate

C21H38O5 (370.2719)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-hexadec-9-enoate

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-hexadec-9-enoate

C21H38O5 (370.2719)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-pentadec-9-enoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-pentadec-9-enoate

C21H38O5 (370.2719)


   

Docosanedioic_acid

1,20-Eicosanedicarboxylic acid

C22H42O4 (370.3083)


Docosanedioic acid is an alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids. It has a role as a metabolite. It is an alpha,omega-dicarboxylic acid and a dicarboxylic fatty acid. It is a conjugate acid of a docosanedioate(2-). It derives from a hydride of a docosane. Docosanedioic acid is a natural product found in Pinus radiata with data available. An alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids.

   

BIS(2-ETHYLHEXYL) ADIPATE

BIS(2-ETHYLHEXYL) ADIPATE

C22H42O4 (370.3083)


   

1-Naphthylacetylspermine

1-Naphthylacetylspermine

C22H34N4O (370.2732)


Naspm (1-Naphthyl acetyl spermine), a synthetic analogue of Joro spider toxin, is a calcium permeable AMPA (CP-AMPA) receptors antagonist.

   

DG(19:1)

DG(8:1(1)_11:0)

C22H42O4 (370.3083)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DG(18:1)

DG(6:0_12:1)

C21H38O5 (370.2719)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Dimethylheptylpyran

Dimethylheptylpyran

C25H38O2 (370.2872)


   

Naphthylacetylspermine

Naphthylacetylspermine

C22H34N4O (370.2732)


   

Hydroxytricosanoic acid

Hydroxytricosanoic acid

C23H46O3 (370.3447)


   

Pentacosahexaenoic acid

Pentacosahexaenoic acid

C25H38O2 (370.2872)


   
   
   
   
   
   

NA-Tryptamine 14:0

NA-Tryptamine 14:0

C24H38N2O (370.2984)


   

FAHFA 10:0/3O-12:0

FAHFA 10:0/3O-12:0

C22H42O4 (370.3083)


   

FAHFA 10:0/O-12:0

FAHFA 10:0/O-12:0

C22H42O4 (370.3083)


   

FAHFA 11:0/3O-11:0

FAHFA 11:0/3O-11:0

C22H42O4 (370.3083)


   

FAHFA 11:0/O-11:0

FAHFA 11:0/O-11:0

C22H42O4 (370.3083)


   

FAHFA 12:0/3O-10:0

FAHFA 12:0/3O-10:0

C22H42O4 (370.3083)


   

FAHFA 12:0/O-10:0

FAHFA 12:0/O-10:0

C22H42O4 (370.3083)


   

FAHFA 13:0/3O-9:0

FAHFA 13:0/3O-9:0

C22H42O4 (370.3083)


   

FAHFA 13:0/O-9:0

FAHFA 13:0/O-9:0

C22H42O4 (370.3083)


   

FAHFA 14:0/3O-8:0

FAHFA 14:0/3O-8:0

C22H42O4 (370.3083)


   

FAHFA 14:0/O-8:0

FAHFA 14:0/O-8:0

C22H42O4 (370.3083)


   

FAHFA 16:0/3O-6:0

FAHFA 16:0/3O-6:0

C22H42O4 (370.3083)


   

FAHFA 4:0/12O-18:0

FAHFA 4:0/12O-18:0

C22H42O4 (370.3083)


   

FAHFA 6:0/3O-16:0

FAHFA 6:0/3O-16:0

C22H42O4 (370.3083)


   

FAHFA 7:0/15O-15:0

FAHFA 7:0/15O-15:0

C22H42O4 (370.3083)


   

FAHFA 8:0/2O-14:0

FAHFA 8:0/2O-14:0

C22H42O4 (370.3083)


   

FAHFA 8:0/O-14:0

FAHFA 8:0/O-14:0

C22H42O4 (370.3083)


   

FAHFA 9:0/3O-13:0

FAHFA 9:0/3O-13:0

C22H42O4 (370.3083)


   

FAHFA 9:0/O-13:0

FAHFA 9:0/O-13:0

C22H42O4 (370.3083)


   

Norcholestenone

Norcholestenone

C26H42O (370.3235)


   
   

(2s,3r,4r)-2-[(14s)-14-hydroxypentadecyl]-4-methyl-5-oxooxolane-3-carboxylic acid

(2s,3r,4r)-2-[(14s)-14-hydroxypentadecyl]-4-methyl-5-oxooxolane-3-carboxylic acid

C21H38O5 (370.2719)


   

3a,5a,8-trimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,9h,10h,13h,14h,14ah,14bh-cycloundeca[e]indene-12-carboxylic acid

3a,5a,8-trimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,9h,10h,13h,14h,14ah,14bh-cycloundeca[e]indene-12-carboxylic acid

C25H38O2 (370.2872)


   

4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carbaldehyde

4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carbaldehyde

C25H38O2 (370.2872)


   

[2-(1h-indol-3-yl)ethyl](pentadecyl)amine

[2-(1h-indol-3-yl)ethyl](pentadecyl)amine

C25H42N2 (370.3348)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

2-[(1s,4s,6r,10r,12r)-1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoic acid

2-[(1s,4s,6r,10r,12r)-1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoic acid

C25H38O2 (370.2872)


   

(4s)-7,11-dimethyl-4-(6-methylhepta-2,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylic acid

(4s)-7,11-dimethyl-4-(6-methylhepta-2,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylic acid

C25H38O2 (370.2872)


   

methyl (1s,2s,3s,6r,7s,10r,11s,12r)-2-decyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl (1s,2s,3s,6r,7s,10r,11s,12r)-2-decyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C25H38O2 (370.2872)


   

(3s,3ar,5ar,14ar,14br)-5a,12,14b-trimethyl-3-(prop-1-en-2-yl)-1h,2h,3h,3ah,4h,5h,6h,9h,10h,13h,14h,14ah-cycloundeca[e]indene-8-carboxylic acid

(3s,3ar,5ar,14ar,14br)-5a,12,14b-trimethyl-3-(prop-1-en-2-yl)-1h,2h,3h,3ah,4h,5h,6h,9h,10h,13h,14h,14ah-cycloundeca[e]indene-8-carboxylic acid

C25H38O2 (370.2872)


   

4b,7,7,10a,12a-pentamethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1,2-dicarbaldehyde

4b,7,7,10a,12a-pentamethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1,2-dicarbaldehyde

C25H38O2 (370.2872)


   

2,3-dihydroxypropyl (9z)-10-methyloctadec-9-enoate

2,3-dihydroxypropyl (9z)-10-methyloctadec-9-enoate

C22H42O4 (370.3083)


   

ethyl (6z,8e)-tricosa-6,8-dien-4,19-diynoate

ethyl (6z,8e)-tricosa-6,8-dien-4,19-diynoate

C25H38O2 (370.2872)


   

(5as,5br,7as,11as,11br,13r,13as)-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-ol

(5as,5br,7as,11as,11br,13r,13as)-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-ol

C25H38O2 (370.2872)


   

(1r,3s,4r,7s,11s,12r)-4-hydroxy-1,4,8-trimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-en-6-one

(1r,3s,4r,7s,11s,12r)-4-hydroxy-1,4,8-trimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-en-6-one

C25H38O2 (370.2872)


   

(6s,8r,11r,12s,15s,16r)-15-[(1s)-1-aminoethyl]-n,7,7,12,16-pentamethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-amine

(6s,8r,11r,12s,15s,16r)-15-[(1s)-1-aminoethyl]-n,7,7,12,16-pentamethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-amine

C25H42N2 (370.3348)


   

(2s,3s,4r)-2-[(14r)-14-hydroxypentadecyl]-4-methyl-5-oxooxolane-3-carboxylic acid

(2s,3s,4r)-2-[(14r)-14-hydroxypentadecyl]-4-methyl-5-oxooxolane-3-carboxylic acid

C21H38O5 (370.2719)


   

ethyl tricosa-6,8-dien-4,19-diynoate

ethyl tricosa-6,8-dien-4,19-diynoate

C25H38O2 (370.2872)


   

(1e,5z,9e,12r,13s)-13-methoxy-1,5,9-trimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene

(1e,5z,9e,12r,13s)-13-methoxy-1,5,9-trimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene

C26H42O (370.3235)


   

(1s,3r,6s,9s,10s,11s,17r,19s,20r)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

(1s,3r,6s,9s,10s,11s,17r,19s,20r)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

C25H38O2 (370.2872)


   

2-(14-hydroxypentadecyl)-4-methyl-5-oxooxolane-3-carboxylic acid

2-(14-hydroxypentadecyl)-4-methyl-5-oxooxolane-3-carboxylic acid

C21H38O5 (370.2719)


   

18R-Hydroxydihydroalloprotolichensterinic acid

NA

C21H38O5 (370.2719)


{"Ingredient_id": "HBIN002149","Ingredient_name": "18R-Hydroxydihydroalloprotolichensterinic acid","Alias": "NA","Ingredient_formula": "C21H38O5","Ingredient_Smile": "CC1C(C(OC1=O)CCCCCCCCCCCCCC(C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38798","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,3e,7e,11r,12s,15s)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carbaldehyde

(1r,3e,7e,11r,12s,15s)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carbaldehyde

C25H38O2 (370.2872)


   

11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H42O (370.3235)


   

4-hydroxy-1,4,8-trimethyl-12-(6-methylhepta-3,5-dien-2-yl)tricyclo[9.3.0.0³,⁷]tetradec-8-en-6-one

4-hydroxy-1,4,8-trimethyl-12-(6-methylhepta-3,5-dien-2-yl)tricyclo[9.3.0.0³,⁷]tetradec-8-en-6-one

C25H38O2 (370.2872)


   

(1s,2r,5r,6s,9r,13r,16s,17r)-16-isopropyl-5,9,10-trimethylpentacyclo[9.7.0.0²,⁶.0²,⁹.0¹³,¹⁷]octadec-10-ene-13-carboxylic acid

(1s,2r,5r,6s,9r,13r,16s,17r)-16-isopropyl-5,9,10-trimethylpentacyclo[9.7.0.0²,⁶.0²,⁹.0¹³,¹⁷]octadec-10-ene-13-carboxylic acid

C25H38O2 (370.2872)


   

(1r,3ar,5as,7s,9as,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3ar,5as,7s,9as,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylic acid

7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylic acid

C25H38O2 (370.2872)


   

(1r,4as,4br,6as,10as,10br,12as)-4b,7,7,10a,12a-pentamethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1,2-dicarbaldehyde

(1r,4as,4br,6as,10as,10br,12as)-4b,7,7,10a,12a-pentamethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1,2-dicarbaldehyde

C25H38O2 (370.2872)


   

21-(furan-2-yl)henicosa-14,16-diyn-1-ol

21-(furan-2-yl)henicosa-14,16-diyn-1-ol

C25H38O2 (370.2872)


   

(1r,3ar,3br,7s,9ar,9br,11ar)-9a,11a-dimethyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3ar,3br,7s,9ar,9br,11ar)-9a,11a-dimethyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

(1e,4s,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylic acid

(1e,4s,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylic acid

C25H38O2 (370.2872)


   

3-(2-hydroxynonadeca-1,3,5-trien-1-yl)phenol

3-(2-hydroxynonadeca-1,3,5-trien-1-yl)phenol

C25H38O2 (370.2872)


   

(1r,3as,3br,5as,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-tetradecahydrocyclopenta[a]phenanthren-7-one

(1r,3as,3br,5as,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-tetradecahydrocyclopenta[a]phenanthren-7-one

C26H42O (370.3235)


   

1,3-dihydroxypropan-2-yl 9-oxooctadec-12-enoate

1,3-dihydroxypropan-2-yl 9-oxooctadec-12-enoate

C21H38O5 (370.2719)


   

(1s,3r,6s,9s,10r,11s,17r,19s,20r)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

(1s,3r,6s,9s,10r,11s,17r,19s,20r)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

C25H38O2 (370.2872)


   

6-hydroxy-1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

6-hydroxy-1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H38O2 (370.2872)


   

1-[1-(dimethylamino)ethyl]-n,n,9a,11a-tetramethyl-1h,2h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-amine

1-[1-(dimethylamino)ethyl]-n,n,9a,11a-tetramethyl-1h,2h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-amine

C25H42N2 (370.3348)


   

14-isopropyl-2,6,17-trimethylpentacyclo[9.7.0.0²,⁹.0⁵,⁹.0¹³,¹⁷]octadec-10-ene-10-carboxylic acid

14-isopropyl-2,6,17-trimethylpentacyclo[9.7.0.0²,⁹.0⁵,⁹.0¹³,¹⁷]octadec-10-ene-10-carboxylic acid

C25H38O2 (370.2872)


   

(7-isopropyl-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl)methyl 2-methylbut-2-enoate

(7-isopropyl-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl)methyl 2-methylbut-2-enoate

C25H38O2 (370.2872)


   

methyl (13s)-13-hydroxydocosanoate

methyl (13s)-13-hydroxydocosanoate

C23H46O3 (370.3447)


   

(1r,3s,6r,9r,10r,11r,13e,17s,19r,20s)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

(1r,3s,6r,9r,10r,11r,13e,17s,19r,20s)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

C25H38O2 (370.2872)


   

13-methoxy-1,5,9-trimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene

13-methoxy-1,5,9-trimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene

C26H42O (370.3235)


   

4-[(3e,7z,11e)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraen-1-yl]-5h-furan-2-one

4-[(3e,7z,11e)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraen-1-yl]-5h-furan-2-one

C25H38O2 (370.2872)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-tetradecahydrocyclopenta[a]phenanthren-7-one

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-tetradecahydrocyclopenta[a]phenanthren-7-one

C26H42O (370.3235)


   

(1r,3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

(1r,3s,4s,6r,7r,8e,11s,12s,13s,16s)-6-hydroxy-1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

(1r,3s,4s,6r,7r,8e,11s,12s,13s,16s)-6-hydroxy-1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H38O2 (370.2872)


   

(1z,4r,7e,11z)-7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylic acid

(1z,4r,7e,11z)-7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylic acid

C25H38O2 (370.2872)


   

n,n,1,6,7,13-hexamethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

n,n,1,6,7,13-hexamethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

C25H42N2 (370.3348)


   

(1s,3r,6s,9s,10r,11s,13e,17r,19s,20r)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

(1s,3r,6s,9s,10r,11s,13e,17r,19s,20r)-3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

C25H38O2 (370.2872)


   

9a,11a-dimethyl-1-[(3z)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

9a,11a-dimethyl-1-[(3z)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

(1r,3as,3br,9ar,9bs,11ar)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3as,3br,9ar,9bs,11ar)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H42O (370.3235)


   

4-[(3e,7e,11e)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraen-1-yl]-5h-furan-2-one

4-[(3e,7e,11e)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraen-1-yl]-5h-furan-2-one

C25H38O2 (370.2872)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

4-[10-(2,2-dimethyl-6-methylidenecyclohexyl)-4,8-dimethyldeca-3,7-dien-1-yl]-5h-furan-2-one

4-[10-(2,2-dimethyl-6-methylidenecyclohexyl)-4,8-dimethyldeca-3,7-dien-1-yl]-5h-furan-2-one

C25H38O2 (370.2872)


   

5a,12,14b-trimethyl-3-(prop-1-en-2-yl)-1h,2h,3h,3ah,4h,5h,6h,9h,10h,13h,14h,14ah-cycloundeca[e]indene-8-carboxylic acid

5a,12,14b-trimethyl-3-(prop-1-en-2-yl)-1h,2h,3h,3ah,4h,5h,6h,9h,10h,13h,14h,14ah-cycloundeca[e]indene-8-carboxylic acid

C25H38O2 (370.2872)


   

2-[1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoic acid

2-[1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoic acid

C25H38O2 (370.2872)


   

1,6-bis[(2s)-2-ethylhexyl] hexanedioate

1,6-bis[(2s)-2-ethylhexyl] hexanedioate

C22H42O4 (370.3083)


   

3-methoxydocosanoic acid

3-methoxydocosanoic acid

C23H46O3 (370.3447)


   

(1e,4r,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylic acid

(1e,4r,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylic acid

C25H38O2 (370.2872)


   

methyl 2-decyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl 2-decyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C25H38O2 (370.2872)


   

(1r,2s,5s,6s,9r,12s,13r,16s)-n,n,1,6,7,13-hexamethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

(1r,2s,5s,6s,9r,12s,13r,16s)-n,n,1,6,7,13-hexamethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

C25H42N2 (370.3348)


   

(1r,3ar,5as,14ar,14br)-3a,5a,8-trimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,9h,10h,13h,14h,14ah,14bh-cycloundeca[e]indene-12-carboxylic acid

(1r,3ar,5as,14ar,14br)-3a,5a,8-trimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,9h,10h,13h,14h,14ah,14bh-cycloundeca[e]indene-12-carboxylic acid

C25H38O2 (370.2872)


   

(1r,3ar,5as,7s,9as,9br,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3ar,5as,7s,9as,9br,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H42O (370.3235)


   

1,3-dihydroxypropan-2-yl (12z)-9-oxooctadec-12-enoate

1,3-dihydroxypropan-2-yl (12z)-9-oxooctadec-12-enoate

C21H38O5 (370.2719)


   

4-[(3e,7e)-10-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-4,8-dimethyldeca-3,7-dien-1-yl]-5h-furan-2-one

4-[(3e,7e)-10-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-4,8-dimethyldeca-3,7-dien-1-yl]-5h-furan-2-one

C25H38O2 (370.2872)


   

methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-decyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-decyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C25H38O2 (370.2872)


   

[(1s,4as,4bs,10as)-7-isopropyl-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]methyl (2e)-2-methylbut-2-enoate

[(1s,4as,4bs,10as)-7-isopropyl-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]methyl (2e)-2-methylbut-2-enoate

C25H38O2 (370.2872)


   

3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

3,6,19-trimethyl-9-(prop-1-en-2-yl)-16-oxapentacyclo[12.5.1.0³,¹¹.0⁶,¹⁰.0¹⁷,²⁰]icos-13-en-17-ol

C25H38O2 (370.2872)


   

4-[(3e,7e)-10-(2,2-dimethyl-6-methylidenecyclohexyl)-4,8-dimethyldeca-3,7-dien-1-yl]-5h-furan-2-one

4-[(3e,7e)-10-(2,2-dimethyl-6-methylidenecyclohexyl)-4,8-dimethyldeca-3,7-dien-1-yl]-5h-furan-2-one

C25H38O2 (370.2872)


   

(2s,3r,4s)-2-[(14s)-14-hydroxypentadecyl]-4-methyl-5-oxooxolane-3-carboxylic acid

(2s,3r,4s)-2-[(14s)-14-hydroxypentadecyl]-4-methyl-5-oxooxolane-3-carboxylic acid

C21H38O5 (370.2719)


   

15-(1-aminoethyl)-n,7,7,12,16-pentamethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-amine

15-(1-aminoethyl)-n,7,7,12,16-pentamethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-amine

C25H42N2 (370.3348)


   

methyl 13-hydroxydocosanoate

methyl 13-hydroxydocosanoate

C23H46O3 (370.3447)


   

4-(4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraen-1-yl)-5h-furan-2-one

4-(4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraen-1-yl)-5h-furan-2-one

C25H38O2 (370.2872)